Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 6/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 3/20 | 0.49 |
| ▸ | DRD2 | P14416 | 2/20 | 0.49 |
| ▸ | HTR2B | P41595 | 2/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6844055 | 0.99 | HTR2A (0.55) | HTR2AHTR1ATMEM97HTR2CDRD2 | |
| SCHEMBL6847393 | 0.87 | HTR2A (0.71) | HTR2AHTR1ATMEM97HTR2CDRD2 | |
| SCHEMBL16364824 | 0.83 | HTR2A (0.75) | HTR2AHTR1ATMEM97HTR2CDRD2 | |
| SCHEMBL6844015 | 0.80 | ALDH1A1 (0.72) | HTR2AHTR1ATMEM97HTR2CDRD2 | |
| Hydrochloric Acid SCHEMBL6845551 | 0.79 | KDM4E (0.70) | HTR2AHTR1ATMEM97HTR2CDRD2 | |
| SCHEMBL6845446 | 0.79 | HTR2A (0.61) | HTR2AHTR1ATMEM97HTR2CDRD2 | |
| Hydrochloric Acid SCHEMBL6844018 | 0.78 | HTR2A (0.60) | HTR2AHTR1ATMEM97HTR2CDRD2 | |
| SCHEMBL6844610 | 0.78 | HTR2A (0.59) | HTR2AHTR1ATMEM97HTR2CDRD2 | |
| SCHEMBL6844606 | 0.78 | HTR2A (0.59) | HTR2AHTR1ATMEM97HTR2CDRD2 | |
| SCHEMBL6845502 | 0.78 | HTR2A (0.59) | HTR2AHTR1ATMEM97HTR2CDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040176413-A1 | Serotonin antagonists | AVENTIS PHARMACEUTICALS INC. (US) | 2004-09-09 | — | — | US | disclosed |
| US-20030212141-A1 | Serotonin antagonists | NIEDUZAK THADDEUS R (US) | 2003-11-13 | — | — | US | disclosed |
| US-20030083325-A1 | Serotonin antagonists | BANK ONE, N.A. | 2003-05-01 | — | — | US | disclosed |
| US-20020002174-A1 | Serotonin antagonists | NIEDUZAK THADDEUS R (US) | 2002-01-03 | — | — | US | disclosed |
| EP-0637306-B1 | 4-IMIDOMETHYL-1- [2'-PHENYL-2'-OXOETHYL]- PIPERIDINES AS SEROTONIN 5HT 2-ANTAGONISTS, THEIR PREPARATION AND USE IN THERAPY | MERRELL PHARMA INC (US) | 2001-05-30 | — | — | EP | disclosed |
| EP-0637306-A1 | 4-IMIDOMETHYL-1- 2'PHENYL-2'OXOETHYL-] PIPERIDINES AS SEROTONIN 5HT 2?-ANTAGONISTS, THEIR PREPARATION AND USE IN THERAPY | MERRELL PHARMACEUTICALS INC. (US) | 1995-02-08 | — | — | EP | disclosed |
| WO-1993022309-A1 | 4-IMIDOMETHYL-1-[2'PHENYL-2'OXOETHYL-] PIPERIDINES AS SEROTONIN 5HT2-ANTAGONISTS, THEIR PREPARATION AND USE IN THERAPY | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176413-A1 | Serotonin antagonists | TPH2, TPH1, HTR1A | HTR2A 4/4885HTR1A 3/4885TMEM97 417/4885 |
| US-20020002174-A1 | Serotonin antagonists | TPH2, TPH1, HTR1A | HTR2A 4/4885HTR1A 3/4885TMEM97 417/4885 |
| US-20030083325-A1 | Serotonin antagonists | TPH2, TPH1, HTR1A | HTR2A 4/4885HTR1A 3/4885TMEM97 417/4885 |
| US-20030212141-A1 | Serotonin antagonists | TPH2, TPH1, HTR1A | HTR2A 4/4885HTR1A 3/4885TMEM97 417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.